Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's ...
Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...
Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...
A severe storm earlier this week led to a power outage at a data center in Groton, Connecticut. The area experienced high ...
Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent ...
Pfizer Inc. is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...
All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...
We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...